<< Back To Authors

Overview

Benjamin Ryan

Editor-at-Large for POZ and its sister publications Hep, Cancer Health and Real Health, where he covers the science of HIV, hepatitis C and cancer. He has also written for The New York Times, The Guardian, New York, The Nation, The Atlantic, The Marshall Project, The Village Voice, The New York Observer, Men's Journal, City & State, Quartz, Out and The Advocate.

Articles

Researchers Issue Recommendations for Measuring HIV Reservoir in Cure Trials

The BEAT-HIV Martin Delaney Collaboratory has issued the first comprehensive set of recommendations for such assessments.

“Healthy Choices” Intervention for Youths With HIV Worked Better in Clinic Setting

The intervention was associated with a higher rate of viral suppression and lower alcohol use when given in a clinic rather than at home.

Cigarette with blue smoke on black background

Smoking Tied to Worse Mental Health, Substance Use In Gay Men, Trans Women

A recent study analyzed smoking’s ties to substance use and mental, psychological and general health in sexual minority men and trans women.

HIV, Hep C Testing at Detox Centers Needs Strong Linkage-to-Care Effort

A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.

“Unprecedented” Transmission of Highly Drug-Resistant HIV in France

Researchers are surprised and concerned that a strain of HIV that is so broadly resistant to treatment even has the capacity to transmit.

Female medical doctor holding red heart shape in hand with graphic of heart beat, cardiology and insurance concept

Among Women, HIV Is Tied to High Rates of Chronic Health Conditions

High blood pressure, diabetes, lung disease and cardiovascular disease are all more prevalent among women with HIV.

Regular Weed Use Doesn’t Seem to Worsen HIV’s Harm to the Brain

HIV leads to brain inflammation and cognitive decline, but adding marijuana to the mix doesn’t seem to further such damage.

STI Testing Rate for Gay Men on PrEP Is Concerningly Insufficient

This finding calls into question research that has projected that frequent testing among men on PrEP could drive down STI rates.

Hot topics

Forums: Support and discussion

Blogs: The community speaks

POZ Stories: Get inspired

Magazine: Search the archives

HIV: The Basics

Recursos de VIH/SIDA en Español

AIDS Is Everyday

Ask POZ

New Long-Acting Injectable HIV Drug Shows Promise in Monkey Study

The D-peptide HIV entry inhibitor CPT31 is being developed with hopes it could be injected quarterly for both treatment and prevention.

Even Short Counseling Sessions Can Reduce STI Risk

The U.S. Preventive Services Task Force has issued updated guidelines for sexually transmitted infection prevention.

Integrase Inhibitors Tied to Fewer Potentially Harmful Drug Interactions

Researchers looked at potential drug-drug interactions among Swiss people with HIV and compared them with a cohort from 2008.

Dovato Shows Promise as a Rapid Test-and-Treat HIV Regimen

A high success rate was seen halfway into a 48-week study in which people with HIV started treatment within two weeks of diagnosis.

Diabetes Drug Metformin Tied to Weight Loss in People With HIV

A small study of people with HIV who did not have diabetes also found that 12 weeks of metformin improved gut microbiome health.

Drug Use, Unstable Housing Tied to Lack of Hep C Treatment in People With HIV

A new study’s findings have led researchers to challenge physicians’ biases against certain groups.

Taking PrEP Only For a Vacation Is an Option for Gay and Bi Men

A study found that men who started PrEP a week before a vacation and stopped a week after coming home adhered well to the daily regimen.

Fatty Liver Disease Tied to Metabolic Health Conditions in People With HIV

As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.